Bowhead Specialty (NYSE:BOW) Given New $30.00 Price Target at JPMorgan Chase & Co.

Bowhead Specialty (NYSE:BOW - Get Free Report) had its target price boosted by stock analysts at JPMorgan Chase & Co. from $26.00 to $30.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price would indicate a potential downside of 7.75% from the stock's previous close.

Other equities analysts have also issued research reports about the company. Royal Bank of Canada raised their price objective on Bowhead Specialty from $32.00 to $35.00 and gave the stock an "outperform" rating in a report on Wednesday. JMP Securities raised their price target on Bowhead Specialty from $32.00 to $33.00 and gave the stock a "market outperform" rating in a research note on Wednesday. Finally, Keefe, Bruyette & Woods boosted their price objective on Bowhead Specialty from $30.00 to $33.00 and gave the company a "market perform" rating in a research note on Tuesday, October 29th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $31.40.

Bowhead Specialty Price Performance

Bowhead Specialty stock traded up $1.32 during midday trading on Thursday, reaching $32.52. The company's stock had a trading volume of 357,826 shares, compared to its average volume of 185,517. The stock's 50-day moving average is $29.50. Bowhead Specialty has a fifty-two week low of $22.14 and a fifty-two week high of $32.62.

Bowhead Specialty (NYSE:BOW - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.38 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.38. The business had revenue of $116.76 million during the quarter, compared to analyst estimates of $113.00 million. On average, research analysts expect that Bowhead Specialty will post 1.3 earnings per share for the current fiscal year.

Insider Buying and Selling at Bowhead Specialty

In other Bowhead Specialty news, Director Family Mutual Insuran American sold 1,362,285 shares of Bowhead Specialty stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $27.70, for a total value of $37,735,294.50. Following the transaction, the director now directly owns 4,700,761 shares in the company, valued at approximately $130,211,079.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Hedge Funds Weigh In On Bowhead Specialty

Hedge funds and other institutional investors have recently bought and sold shares of the company. American Century Companies Inc. acquired a new stake in shares of Bowhead Specialty in the 2nd quarter worth $23,148,000. Victory Capital Management Inc. lifted its position in Bowhead Specialty by 4.5% in the third quarter. Victory Capital Management Inc. now owns 658,595 shares of the company's stock valued at $18,447,000 after purchasing an additional 28,235 shares during the period. Driehaus Capital Management LLC purchased a new stake in Bowhead Specialty in the 2nd quarter valued at approximately $7,866,000. Emerald Advisers LLC increased its position in Bowhead Specialty by 3.3% during the 3rd quarter. Emerald Advisers LLC now owns 242,633 shares of the company's stock worth $6,796,000 after purchasing an additional 7,683 shares during the period. Finally, Emerald Mutual Fund Advisers Trust raised its stake in shares of Bowhead Specialty by 0.5% during the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 194,333 shares of the company's stock worth $5,443,000 after buying an additional 937 shares in the last quarter.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.